Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus

[1]  J. McLellan,et al.  Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins , 2022, Nature Communications.

[2]  D. Hassabis,et al.  Protein complex prediction with AlphaFold-Multimer , 2021, bioRxiv.

[3]  G. Boivin,et al.  Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac® , 2021, Vaccines.

[4]  J. Mascola,et al.  Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses , 2021, Proceedings of the National Academy of Sciences.

[5]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[6]  T. Nagy,et al.  Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein , 2021, Journal of virology.

[7]  M. Lucero,et al.  Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study , 2021, The Lancet Global Health.

[8]  Conrad C. Huang,et al.  UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.

[9]  M. Takeda,et al.  Recent Molecular Evolution of Human Metapneumovirus (HMPV): Subdivision of HMPV A2b Strains , 2020, Microorganisms.

[10]  J Gomez-Blanco,et al.  DeepEMhancer: a deep learning solution for cryo-EM volume post-processing , 2020, Communications Biology.

[11]  L. Rudenko,et al.  Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus , 2020, Pathogens.

[12]  J. Mousa,et al.  Antibody recognition of the Pneumovirus fusion protein trimer interface , 2020, bioRxiv.

[13]  C. Couture,et al.  Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice. , 2020, Vaccine.

[14]  David J. Fleet,et al.  Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction , 2019, Nature Methods.

[15]  Christopher J. Williams,et al.  Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix , 2019, Acta crystallographica. Section D, Structural biology.

[16]  C. Couture,et al.  Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development , 2019, bioRxiv.

[17]  B. Graham,et al.  Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. , 2019, Immunity.

[18]  H. Su,et al.  Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes , 2019, mAbs.

[19]  R. Tripp,et al.  A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo , 2019, Journal of Virology.

[20]  G. Kelsoe,et al.  Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope. , 2019, Cell host & microbe.

[21]  I. Wilson,et al.  A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface , 2019, Cell.

[22]  T. Kepler,et al.  Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism , 2019, Cell.

[23]  J. McLellan,et al.  Transient opening of trimeric prefusion RSV F proteins , 2019, Nature Communications.

[24]  Tristan Ian Croll,et al.  ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.

[25]  A. Sivasubramanian,et al.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation , 2018, Immunity.

[26]  Conrad C. Huang,et al.  UCSF ChimeraX: Meeting modern challenges in visualization and analysis , 2018, Protein science : a publication of the Protein Society.

[27]  J. McLellan,et al.  Chimeric Pneumoviridae fusion proteins as immunogens to induce cross‐neutralizing antibody responses , 2017, EMBO molecular medicine.

[28]  J. McLellan,et al.  Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein , 2017, Nature Communications.

[29]  R. Karron,et al.  Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children , 2017, Journal of the Pediatric Infectious Diseases Society.

[30]  David J. Fleet,et al.  cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination , 2017, Nature Methods.

[31]  R. Lamb,et al.  Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus , 2017, Nature Microbiology.

[32]  B. Graham,et al.  Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors , 2016, Science Immunology.

[33]  Baoshan Zhang,et al.  Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination , 2016, Nature Medicine.

[34]  J. McLellan,et al.  Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation , 2016, PLoS pathogens.

[35]  Stacy E. Smith,et al.  Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues , 2016, Journal of Virology.

[36]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[37]  Sebastian Kelm,et al.  SAbPred: a structure-based antibody prediction server , 2016, Nucleic Acids Res..

[38]  J. Melero,et al.  The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals. , 2015, Virus research.

[39]  Steven H. Kleinstein,et al.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data , 2015, Bioinform..

[40]  J. McLellan.  Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. , 2015, Current opinion in virology.

[41]  Z. Chen,et al.  Broadly Neutralizing Human Monoclonal Antibody Exhibits In Vivo Ef fi cacy Against Both Human Metapneumovirus and Respiratory Syncytial Virus , 2014 .

[42]  John J. Erickson,et al.  Human Metapneumovirus Virus-Like Particles Induce Protective B and T Cell Responses in a Mouse Model , 2014, Journal of Virology.

[43]  M. Peeples,et al.  Roles of the Putative Integrin-Binding Motif of the Human Metapneumovirus Fusion (F) Protein in Cell-Cell Fusion, Viral Infectivity, and Pathogenesis , 2014, Journal of Virology.

[44]  F. Baldanti,et al.  Cross-neutralization of four paramyxoviruses by a human monoclonal antibody , 2013, Nature.

[45]  D. Lavillette,et al.  Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice. , 2013, Vaccine.

[46]  U. Baxa,et al.  Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody , 2013, Science.

[47]  J. Melero,et al.  Entry of Enveloped Viruses into Host Cells: Membrane Fusion , 2013, Sub-cellular biochemistry.

[48]  Chin-fen Yang,et al.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages , 2013, Archives of Virology.

[49]  Reagan G. Cox,et al.  The Human Metapneumovirus Fusion Protein Mediates Entry via an Interaction with RGD-Binding Integrins , 2012, Journal of Virology.

[50]  R. Lamb,et al.  Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneumovirus Antigenic Site , 2012, Nature Structural &Molecular Biology.

[51]  R. Dutch,et al.  Human Metapneumovirus (HMPV) Binding and Infection Are Mediated by Interactions between the HMPV Fusion Protein and Heparan Sulfate , 2012, Journal of Virology.

[52]  C. Mandl,et al.  Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers , 2011, Proceedings of the National Academy of Sciences.

[53]  P. Kwong,et al.  Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F , 2010, Journal of Virology.

[54]  M. Egholm,et al.  Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements , 2010, The Journal of Immunology.

[55]  Joyce E. Johnson,et al.  Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. , 2010, Vaccine.

[56]  D. Wright,et al.  Integrin αvβ1 promotes infection by human metapneumovirus , 2009, Proceedings of the National Academy of Sciences.

[57]  Derick R. Peterson,et al.  Human metapneumovirus infections in adults: another piece of the puzzle. , 2008, Archives of internal medicine.

[58]  N. Patel,et al.  Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus , 2008, The Journal of general virology.

[59]  R. Dutch,et al.  Low-pH Triggering of Human Metapneumovirus Fusion: Essential Residues and Importance in Entry , 2008, Journal of Virology.

[60]  D. Gordon,et al.  Role of Cellular Glycosaminoglycans and Charged Regions of Viral G Protein in Human Metapneumovirus Infection , 2008, Journal of Virology.

[61]  A. Osterhaus,et al.  Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. , 2008, Vaccine.

[62]  M. Takeda,et al.  Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2 , 2008, Journal of Virology.

[63]  C. Couture,et al.  Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. , 2007, The Journal of general virology.

[64]  L. Gutshall,et al.  Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches. , 2007, The Journal of general virology.

[65]  D. Burton,et al.  A Recombinant Human Monoclonal Antibody to Human Metapneumovirus Fusion Protein That Neutralizes Virus In Vitro and Is Effective Therapeutically In Vivo , 2007, Journal of Virology.

[66]  C. Couture,et al.  An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  J. Crowe,et al.  Human Metapneumovirus Fusion Protein Vaccines That Are Immunogenic and Protective in Cotton Rats , 2006, Journal of Virology.

[68]  A. Osterhaus,et al.  Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human Metapneumovirus In Vitro and In Vivo , 2006, Journal of Virology.

[69]  J. Kahn.  Epidemiology of Human Metapneumovirus , 2006, Clinical Microbiology Reviews.

[70]  B. Murphy,et al.  Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. , 2006, Virology.

[71]  B. Murphy,et al.  Infection of Nonhuman Primates with Recombinant Human Metapneumovirus Lacking the SH, G, or M2-2 Protein Categorizes Each as a Nonessential Accessory Protein and Identifies Vaccine Candidates , 2005, Journal of Virology.

[72]  B. Murphy,et al.  Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate , 2004, Journal of Virology.

[73]  A. Osterhaus,et al.  Antigenic and Genetic Variability of Human Metapneumoviruses , 2004, Emerging infectious diseases.

[74]  L. Anderson,et al.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. , 2002, The Journal of infectious diseases.

[75]  L. Anderson,et al.  Characterization of Human Metapneumoviruses Isolated from Patients in North America , 2002, The Journal of infectious diseases.

[76]  A. Osterhaus,et al.  Analysis of the genomic sequence of a human metapneumovirus. , 2002, Virology.

[77]  T. Kuiken,et al.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease , 2001, Nature Medicine.

[78]  A. Steven,et al.  Engineering trimeric fibrous proteins based on bacteriophage T4 adhesins. , 1998, Protein engineering.

[79]  A. Lustig,et al.  Fibritin encoded by bacteriophage T4 gene wac has a parallel triple-stranded alpha-helical coiled-coil structure. , 1994, Journal of molecular biology.

[80]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[81]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .